In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens.
Barry
A L
AL
Clinical Microbiology Institute, Tualatin, Oregon 97062.
D000658:Amoxicillin / Q000494:pharmacology*; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000494:pharmacology*; D004917:Erythromycin / Q000031:analogs & derivatives / Q000494:pharmacology*; D006193:Haemophilus influenzae / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D001936:Moraxella catarrhalis / Q000187:drug effects*; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology; D013296:Streptococcus pneumoniae / Q000187:drug effects*
D004917:Erythromycin; D000658:Amoxicillin; D002439:Cefotaxime